Portfolio company
Veracyte
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Foundation Medicine
This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.
Delphi Diagnostics
This company develops genomic tests for breast cancer to assist clinicians and patients in personalising treatment decisions and predicting long-term survival outcomes.
Strata Oncology
This company provides genomic profiling tests and data software to help healthcare systems and pharmaceutical firms match cancer patients with precision therapies.
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
Guardant Health
The company develops blood-based tests to detect and monitor cancer for patients, healthcare providers, and biopharmaceutical researchers.
AnchorDx
This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.
Orbit Genomics
This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.
Foresight Diagnostics
This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.
